NCDB cancer bytes
The potential role of NCDB data in treating rare malignancy is explored.
This article compares demographic data of astrocytomas and glioblastomas patients documented in the NCDB, a hospital-based cancer registry, with cases in the Central Brain Tumor Registry of the U.S.
Both retrospective and prospective data are assessed to determine the quality of life outcomes for patients undergoing brachytherapy to treat prostate cancer.
To determine the impact of age on thyroid cancer mortality, researchers investigated trends in outcomes from these cases in the National Cancer Database.
Because many cases of ductal carcinoma in situ (DCIS) may remain stable without excision, more clinical trials are exploring the role of active surveillance in DCIS management.
More in this category
- Endometrial cancer: An increasingly common gynecologic malignancy
- Using data to plan cancer prevention and screening activities
- Strategically reversing the rising incidence of melanoma in younger patients
- The impact of financial barriers on access to quality care in breast cancer
- Using the NCDB to explore trends in cancer